About ten days after having suspended clinical trials on hydroxychloroquine, the World Health Organization has changed your mind by deciding to allow, again, tests with chloroquine.
“There is no reason to modify the protocol of clinical trials” concerning the use of chloroquine and its derivatives in the treatment of coronavirus, concluded the WHO, thus taking the decision to resume the clinical trials it had suspended.
Recall that WHO had decided to launch tests to find a treatment for COVID-19, at the end of April. The latter were then suspended following recommendations from a medical journal, The Lancet. The organization therefore returns to its positions and resumes the tests.
At a press conference given in Geneva, the WHO explained this resumption of tests having noticed that he had seen “no difference in mortality”.
This news should exult Professor Didier Raoult, who campaigns for the use of chloroquine against the coronavirus since the start of the pandemic. The French scientist has always challenged the WHO’s decision to suspend clinical trials on chloroquine.
In Tunisia, the treatment of the Chloroquine of the patients with COVID-19 was suspended in all hospitals, announced on May 27, Jalila Ben Khalil, member of the permanent committee for the fight against the coronavirus. A decision which took place following the declarations of the WHO as a precaution.
The WHO had announced the temporary suspension of clinical trials with the hydroxychloroquine it conducts with its partners in several countries, following the publication of a study, in the medical journal The Lancet deeming ineffective, even harmful, the use of chloroquine or its derivatives such as hydroxychloro against covid-19.
